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ABSTRACT
Vascular and Mechanical Changes in Bone in Response to Chronic Ischemia and
Mechanical Loading
Michael Govea

Peripheral artery disease (PAD) and osteoporosis have recently been shown to
be associated; with the parallel occurrence suggesting that PAD related ischemia may
cause or enhance the onset of osteoporosis. In order to determine the mechanism
linking osteoporosis and PAD this paper will examine the effects of ischemia and
mechanical stimulation on bone remodeling. An immunohistochemistry protocol for
vessel marking in bone was also developed. Ischemia was induced in a mouse model
to determine vascular and mechanical property changes in bone in response to
hypoxia, and mechanical loading-induced remodeling was analyzed for vascular
changes. Both ischemia and mechanical loading increased bone vessel density, with
ischemic bone increases seen at day 7 and 14. Bone stiffness increased after induced
ischemia at day 28. These results point to resultant hypoxia from ischemia drives
bone mechanical property changes, likely through stimulation of bone remodeling.
We also conclude that an increase in vessel density is seen after induced mechanical
loading of bone. Establishing the vascular contribution to the remodeling process may
reveal treatment opportunities for remodeling-dependent pathologies such as
osteoporosis.

Keywords: Ischemia, Induced Remodeling, Angiogenesis, Osteoporosis,
Peripheral Artery Disease
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CHAPTER 1: INTRODUCTION

Peripheral artery disease (PAD) and osteoporosis, although affecting separate
organ systems, have recently shown associated and parallel occurrence. The diseases
share common risk factors [1], including age dependent association [2], and PAD
occurrence is 5 times greater in women with osteoporosis than women without the
condition [3]. To understand the relationship between these diseases, this chapter
provides an overview of the normal vascular and bone remodeling systems, the
individual disease pathologies, and a discussion of the potential interplay between the
two systems.

Normal Vascular Function
The circulatory system is the most vital component of a multi-cellular
organism, because it performs the nutrient and waste exchange, including oxygen
delivery, required to maintain homeostasis [4, 5]. This critical function arises from
the limited distances molecules can travel via diffusion, such that in a complex
multicellular organism, convective and diffusive transport effectively contribute to
the exchange of nutrients and wastes in all cells. This exchange is accomplished with
a highly branched network [4] that can be divided into arterial and venous sides. The
arterial side of the vasculature carries oxygenated blood away from the heart (except
in the case of the pulmonary circuit) and is responsible for flow and pressure
regulation of the blood supply [4, 5]. The venous side of the vasculature transports
deoxygenated blood back to the heart and is primarily responsible for the
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inflammatory response (venules) and function as the blood reservoir [4, 5].
Interfacing the two sides of the vascular system are the capillaries, the smallest
vessels that are the site for nutrient and waste exchange [4, 5].
Within the main vessel classes, arterioles and venules reside in the network as
a transition between the arteries and capillaries and the capillaries and veins,
respectively. Arterioles and venules are larger in diameter than the capillaries but
smaller than their respective main vessels [4, 6, 7]. The network of arterioles,
capillaries and venules reside within the tissues and comprise what is typically
referred to as microvasculature. Acting as the functional component of the circulatory
system, the microvasculature is directly responsible for the nutrient and waste
exchange at the tissue and cellular level [4, 5]. Characteristics of the
microvasculature, such as total vessel area, influence flow within a given region. For
tissues to function properly, delivery of blood must be modulated to match nutrient
and oxygen delivery with nutrient and oxygen demand [4, 8]. Individual vessel types
of the microvasculature provide unique contributions to the system’s function.
The rate of oxygen and nutrient exchange is grossly dependent on the amount
of blood flowing through a given region. Blood flow regulation is accomplished by
the arterioles in the microvascular network [4, 6, 7], due to their ability to constrict or
dilate with the help of smooth muscle cells (SMC), which contract or relax,
effectively modulating blood flow to a given downstream tissue [4, 5, 8]. In addition
to blood flow, vessel structure greatly contributes to mass transfer, with capillaries
having the thinnest walls, a lack of smooth muscle, and small diameter to facilitate
maximal delivery [4, 5]. Total capillary area and variability in capillary structure
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within a local microvasculature also contribute to the capacity for mass transfer.
Lastly, partial pressures dictates oxygen diffusion into tissue; the greater the oxygen
pressure differential, the greater the gas exchange [4]. Interplay of these
microvascular components dictates the mass transfer profile within a tissue.
Different tissues have unique vascular requirements determined by factors
such as: pressure gradients, physiologic function, and spatial properties. For example,
the muscle, kidney and liver have similar spatial and metabolic needs, but due to their
physiologic functions, capillary structure varies dramatically. SEM images compiled
in Figure 1 illustrate this eventuality, and highlight the distinct structural differences
between the vessel networks. Vascular networks in bone are physically constrained
by the tissue itself, thus are primarily dendritic (stem and leaf branching pattern) [9]
and the capillary number per arteriole in bone is greater than what is typically seen in
muscle, as evidenced by a single arteriole feeding a large capillary network in the
humeral growth plate, for example [9]. Figure 2 illustrates the dendritic vascular
networks in bone. In addition to nutrient and waste exchange, bone vasculature has a
large influence on local bone deposition [9]. For example, in fracture repair,
vasculature invades the tissue void and accompanying osteoclasts degrade any
cartilage or matrix prior to mineralization in regions adjacent to the invading
vasculature [9].
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Figure 1: Tissue specific microvascular networks.
The SEM comparisons highlight the distinct morphological differences of the
vasculature depending on the organ/tissue. White bar is 40 um [10].
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Figure 2: Microvasculature in bone.
Top figure depicts periosteal vasculature with the main arteriole and venule
marked (Ma and Mv). The bottom figure illustrates vasculature in the subchrondral
bone, with the C indicating vascular cartilage and the arrows in the
sub-figure indicating capillary loops. Used with permission [11]

To account for variability in microvascular needs between tissues, the arteryarteriole-capillary network configuration can exhibit different arrangements. A
dendritic, or stem and leaf, network features a main feed vessel branching into two
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smaller, parallel daughter vessels, followed by those daughter vessels splitting into
two more smaller vessels, and so on [6, 7, 12]. Many vessel branches, or bifurcations,
occur before the resulting daughter vessels reach capillary size. All vessels in the
resultant network are connected in a linear and one directional manner, with each
vessel pair being fed by only the ‘parent’ vessel upstream with no other flow
influences [6, 7, 12]. Arcaded networks feature similar bifurcation characteristics, but
not all vessels are connected in a strictly sequential orientation. The two network
configurations are illustrated in Figure 3. Anastamoses, the connection between two
arterioles of the same relative size, are prevalent, and result in many vessels of similar
diameter running in parallel with each other, affecting flow profiles is downstream
vessels [12]. These parallel running vessels are termed collaterals and function,
amongst other things, to maintain a constant blood pressure in the tissue and regulate
blood flow [4-7, 12]. The uniform tissue flow parameters ensure consistent oxygen
and nutrient exchange within the tissue. The presence of collaterals facilitates this
homogenous mass transfer profile, enabling constant fluid parameters and
maintaining tissue homeostasis.
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Figure 3: Vessel network arrangements.
Examples of dendritic (A) and arcaded (B) vessel network arrangements.
Only illustrating the arterial side of the network fed by one main vessel,
with bifurcations and anastomoses marked with red dots.
Direction of flow is also indicated by the arrow

In addition to tissue effects, blood flow is also dependent on vessel topology
because flow is largely dictated by vessel diameter. Network morphology is tied to
tissue anatomy and physiology, for example, the kidney requires a large network of
smaller vessels to increase mass transfer. Acutely, flow can be modulated by dilation
or constriction of vessels, from either a conducted or flow-mediated response
[13].Chronically flow is altered through structural remodeling, driven by
environmental or flow-based alterations [12, 14]. An example of structural
remodeling attributed solely to flow mediated changes is illustrated in Figure 4. The
most common structural remodeling processes are arteriogenesis and angiogenesis
and play a vital role in preserving tissue functionality.
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Figure 4: Depiction of vessel network alterations.
Flow mediated vascular changes [14]. Am Physiol Soc, used with permission

Arteriogenesis
Arteriogenesis is the increase in lumen size in preexisting vessels or
arterialization of capillaries [15]. An occlusion or obstruction in an artery or arteriole
will result in reduction of blood flow to distal tissues. Arteriogenesis occurs to
normalize the increased shear resulting from the occlusion experienced by implicated
collaterals, through the manipulation of collateral diameter or number, termed
collateral enlargement or capillary arterialization, respectively [12, 15, 16]. A
decrease in the blood flow to the impaired tissue will lead to an increased pressure
drop in the collaterals that circumvent the occlusion. An increased pressure drop leads
8

to an increase in blood flow in these effected collaterals, and subsequently, an
increase in shear stress [16, 17].
The primary stimulating factor for both forms of arteriogenesis is an increase
in fluid shear stress (FSS) along the luminal surface of the endothelium [15, 16, 18,
19]. Elevated FSS causes initial endothelial distress and vasodilation in parallel
collaterals in response to acute occlusion [8, 17]. Highly arcaded vascular networks
do not show appreciable loss of perfusion immediately following occlusions due to
the initial dilatory response, but networks comprised primarily of dendritic vessel
connections, as in bone, show much greater initial loss of perfusion [12]. The
presence of collaterals appears to be tissue specific and dependent on VEGF and the
VEFG-A gene expression [20].
Due to the vessel network configuration and spatial boundaries present in
bone, capillary arterialization is the most likely mechanism of arteriogenesis to occur.
In order for enlarged capillaries to undergo arterialization, SMCs must be recruited in
one of several ways: proliferation or migration of SMC from upstream arterioles,
pericyte differentiation (as determined by expression of smooth muscle markers, such
as alpha actin) [12], or fibroblasts migration and subsequent differentiation into a
smooth muscle phenotype [21]. Platelet derived growth factor (PDGF-B) is
implicated in arterialization, impacting SMC proliferation [22].
Fluid flow alterations, associated wall stresses, and endothelial inflammation
appear to regulate the arterialization process leading to capillary remodeling [12, 17].
Fibroblasts are activated through endothelial cell distress signals caused by increases
in wall stresses or inflammatory conditions such as oxidative stress [17, 21]. Once
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sufficient arterialization and/or collateral enlargement has occurred, blood flow
within each vessel will increase. Due to the increase in blood flow, the initial
increased pressure gradient subsides resulting in reduction in fluid shear stress,
signaling the maturation of the vessel/vessel network and arteriogenesis is halted, as
the stimulus is no longer present [19].
Although the vasculature is remodeled in response to the tissue ischemia, the
original occluded artery is not replaced by a single vessel but by increases in existing
vessel networks [19]. Not all vessels in the network undergo remodeling and the
optimal total tissue resistance is not fully reestablished because of the increased
number of vessels that compensate for the larger occluded artery [19]. Despite this,
arteriogenesis is a critical response that results in vascular compensation for an
occlusive event.

Angiogenesis
Insufficient blood flow, termed ischemia, will result in a diminished capacity
for oxygen and nutrient delivery. The function of angiogenesis is to alleviate a
hypoxic environment by network expansion in ischemic tissues [8, 15, 23, 24].
Sprouting of new capillaries and splitting of existing capillaries, termed
intussusception, helps re-establish sufficient oxygen delivery to the tissues [25, 26].
Sprouting angiogenesis, defined as creation of new capillaries, commences
with the activation, or distress, of the local endothelial cells [15]. Hypoxia, or lack of
oxygen, is the primary stimulus for sprouting angiogenesis which initially results in
increased permeability and cell proliferation in response to hypoxia [8, 15, 25, 27].
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Under normal conditions, oxygen is present in the intracellular environment and binds
to Hypoxia Inducible Factor (HIF), rendering it ineffective. An unbound HIF
molecule (in a hypoxic environment) is one of the main perpetrators of the
angiogenesis and leads to several cellular responses [8, 15, 25, 27] including cytokine
release and initiation of growth factor production. Fibroblast growth factor (FGF) and
vascular endothelial growth factor (VEGF), among other molecules, are some of
HIF’s most relevant downstream transcriptional targets [8, 15].
Following increased vessel permeability driven by HIF activated VEGF,
degradation of the vessel basement membrane and local extracellular matrix (ECM)
occurs [15, 28]. ECM degradation, through VEGF activation of matrix
metalloprotienases (MMP), provides a region for vessel growth [15]. Local VEGF
also triggers endothelial cell proliferation and differentiation in proportion to and in
accordance with the local VEFG gradient [15, 28]. FGFs induce mitogenic (cellular
division) qualities as well, and influence chemotactic (cellular movement) properties
of sprouting cells leading to endothelial migration [23].Cell to cell contacts are
established with adjacent, proliferating cells [23] facilitated by platelet endothelial
cell adhesion molecule (PECAM); the main cellular adhesion and signaling protein
within the endothelium [28]. With continued VEGF and FGF exposure, proliferation
and migration continue to form a new capillary loop, and interaction with surrounding
ECM and perivascular cells promotes lumen formation [15].
Vessel lumen development is regulated by a host of factors including VEGF
and occurs through cell reorganization, with the basement membrane reformed by the
endothelial cells themselves [23, 25]. Pericytes, which are structural cells, assist with
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lumen formation and endothelial cell guidance during this vessel growth process [2325]. Capillary loops form within 5 days of response initiation [24, 25, 28] and
increase the mass transfer capacity within the local tissue, partially alleviating the
ischemic environment.
Intususseception is the splitting of capillaries through pillar formation in the
vessel lumen [26], stimulated by increases in shear stress [25, 26] that result in
upregulation of VEGF receptors [28]. Consistent with common angiogenic
modulators, intussusception requires VEGF and FGF [24, 26, 28]. The
intussusception process initiates with a collagen pillar forming at either side of the
lumen and extend from the vessel walls, eventually connecting the opposite sides of
the capillary. As more pillars form and elongate, facilitated by myofibroblasts, a rift
in the lumen arises, splitting the capillary into two distinct vessels [25, 26]. This
angiogenic type does not require much cell proliferation [25, 26], and in adults,
occurs primarily in pulmonary system, with some prevalence in myocardium and
skeletal muscle [25]. With intussusception, blood vessels can be formed more rapidly
than by sprouting [25, 26], by consuming less energy than sprouting [25].
Angiogenesis is vital to the restoration of blood flow to ischemic tissues,
however, angiogenesis alone cannot fully restore necessary blood flow in a model of
chronic ischemia [24]. Because the capillaries have little control of how much blood
is delivered, a robust angiogenic response alone cannot relieve tissue ischemia
without the contribution of upstream arterioles [29].
Tissue damage from vessel occlusion and ischemia is localized, affecting
primarily the capillary and arteriole networks. Because of this occurrence, one can
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expect that most vascular changes will arise within the arteriole and capillary domain
through angiogenesis and arteriogenesis [12]. Knowledge of vessel adaptation will
help reveal interplay between the vascular other physiological systems.

Normal Bone Remodeling
Bone provides mechanical structure through two main tissue types: cortical
and trabecular [5, 30]. Cortical bone is comprised of compact osteons, which form the
outer layer of the bone and provide the bulk of the strength [5, 30]. Trabecular bone
resides inside of the cortical bone, aids in load distribution, and is referred to as
spongy bone because of its porous, matrix structure [5, 30]. Because of its load
bearing function, bone is regularly remodeled [5, 30] and adapts through targeted
sculpting of the tissue [31]. Bone structure is optimized for strength with respect to its
weight, and its trabeculae are approximately aligned with the principal directions of
applied stress [31, 32], indicating that bone adapts its structure in response to local
strain [30].
Bone remodeling involves osteoblasts, osteocytes, and osteoclasts, which
collaborate in basic multicellular units (BMUs) [32], depicted in Figure 5.
Osteoblasts are involved in bone formation and synthesis, osteoclasts dissolve and
resorb damaged or unnecessary bone, and osteocytes are mature osteoblasts that
become integrated into the mineral matrix of bone and sense mechanical loads [5, 3032]. In normal circumstances, the main stimulus for remodeling starts with the
osteocyte. These cells respond to the local environment and mechanical factors such
as stretch, pressure, and flow [30]. Sensing of high strain can trigger remodeling, and

13

formation of microcracks will lead to osteocyte apoptosis, a potent remodeling
stimulator [5, 30-32]. Fatigue loading is the main perpetrator of microcracks, and is
defined as the occurrence of cracks that propagate in the tissue at lower than fracture
magnitudes if the load is applied as a cyclic loading and unloading [30]. The
magnitude of fatigue damage is proportional to bone structure and vascular changes
that occur during the remodeling process [33].

Figure 5: Process of bone remodeling, displaying the main cell types [34]

Microdamage or apoptosis results in osteoclast recruitment to the site of the
crack or damaged cell [5, 30-32]. The osteoclasts dissolve and remove the damaged
tissue, which is then replaced with new tissue by osteoblasts [5, 30-32]. Upon mineral
deposition, osteoblasts become integrated into the boney matrix and mature into
osteocytes [5, 30-32]. Bone endothelium, in locations of damage or growth, actively
recruit osteoclasts for either remodeling or vascular expansion [9]. Recruitment is tied
to the RANK / RANKL complex interaction; RANK is an osteoclast membrane
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receptor and RANKL is the associated ligand expressed on endothelial cells and
osteoblasts [9]. Hematopoietic derived osteoclasts and osteoblasts circulate in the
peripheral vasculature and exist in bone marrow, and while poorly understood, it is
thought that endothelial cell adhesion relocates them from these two sources into the
tissue of interest [9]. However, osteoclast extravasation is not required for bone
removal, evidenced by lower bone mass in non-vascularized tissue compared to
vascularized tissue [9].
Osteoclasts produce heparinase, which releases VEGF from heparin, which is
bound to the ECM, allowing VEGF to activate the VEFG receptor, subsequently
increasing expression of the RANKL complex on osteoblasts, and increasing
expression of RANK on endothelial cells [9, 35]. Local angiogenesis is subsequently
induced by the activation of RANK, for reasons unknown, contributing to the vessel
remodeling as the vasculature advances [9, 35]. Only cells adjacent to capillaries give
rise to bone tissue and eventual mineralization (because of the RANK / RANKL
interactions between the osteoblasts, osteoclasts, and endothelial cells), therefore
implicating any surrounding vasculature in the remodeling process [9, 34]. From
these findings we can deduce that the invading vasculature is a primary factor for
regulation of the ossification process [9], specifically, VEGF appears to regulate
osetogenesis and angiogenesis, and is required for bone formation [9]. Thus,
interaction between both the bone and vascular system dictate normal bone function.
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Impaired Bone Function: Osteoporosis
Osteoporosis is generally described as a systemic skeletal disease,
characterized by deterioration of bone micro-architecture leading to increased bone
fragility [34, 36]. Specifically, osteoporotic bone contains fewer and narrower
trabeculae, with a loss of connectivity between individual trabeculae, and decreased
wall and osteiod (mineralization) thickness attributed to loss in osteocyte density and
viability [37-39]. Osteoporosis is often an asymptomatic condition prior to a fracture
event [36] and clinically, osteopenia and osteoporosis are defined by loss of bone
mass measured in the lumbar spine or hip. Osteopenia and osteoporosis are 1 SD and
2.5 SD, respectively, below the average bone mass of healthy, thirty-year old and sexmatched control subject [37].
Peak bone mass in humans is seen anywhere from 25 to 30 years of age [37],
but from that point in time, fracture rate and osteoporosis increase dramatically with
age [40]. Three to six percent of women have osteoporosis by 50, 50-75% of women
have osteoporosis by age 90 [40] and there is a 40% risk of major fracture for women
over 50 [40]. For men, there is a 1% prevalence at age 50 and 15-28% prevalence at
age 90 [40]. Female osteoporosis is almost exclusively related to menopause, during
which greatly accelerated bone loss can account for 33% of lifetime bone loss [37].
Enhanced bone resorption is the main contributor related to estrogen deficiency, but
in the years following menopause, lack of bone formation is observed and contributes
significantly to the disease onset [34]. Furthermore, duration of menopause is more
important than the age of onset in terms of osteoporosis onset and development, with
longer menopause leading to increased osteoporosis [36]. Additional risk factors for
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developing osteoporosis include alcohol use, tobacco use, drug use, inactivity, and
poverty [41].
Fracture is the primary risk for patients with osteoporosis and there are 1.5
million osteoporosis related fractures per year in the US [41]. The femoral head is
particularly susceptible to osteoporosis [38], and hip fracture accounts for 18% of all
osteoporotic fractures [42]. Osteoporosis and related fractures in the Americas and
Europe contribute to the loss of 2.8 million disability adjusted life years (DALY)
[40], which accounts for 1.75% of DALYs for non communicable diseases in western
society and 0.83% of worldly DALYs [42].
Osteoporosis is likely to be caused by a change in the complex interactions
among regulators of bone cell function [34]. Common cells and molecules involved
are the osteoclasts, osteocytes, osteoblasts, and estrogen, and in osteoporotic patients,
osteoblasts have impaired function leading to inadequate bone formation over time
[34, 39]. More importantly, the osteoclasts seem to be highly activated and
unregulated in osteoporotic patients [34, 39] resulting in excessive bone resorption,
decreased bone mass, and microarchitectural deterioration of the skeleton [34]. The
specific mechanisms are not well identified, but some factors such as estrogen
deficiency seem to contribute to the increase in systemic osteoclast activation [34,
36]. Other factors may be chronic glucocorticoid treatments as well as a host of
cytokines, as they seem to contribute to osteoclast activation and subsequent bone
resorption [34, 37]. The combination of osteoblast dysfunction along with enhanced
osteoclast activity leads to the marked loss in bone mineral density [39].
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Due to the prevalence, morbidity and mortality associated with osteoporosis,
several treatments are currently utilized. Bisphosphonates inactivate osteoclasts [4,
34], leading to decreased resorption, but also an increase in stiffness and microdamage buildup which can have severe long-term complications [4, 34]. Strontium
renelate (SR), although not currently FDA approved, acts as both an anti-resorption
and bone forming drug concurrently [43]. SR increases cortical bone thickness in
osteoporotic patients and induces a more robust trabecular bone network [43].
Treatments thus far have focused primarily on targeting the osteoclasts and
osteoblasts, but other cellular mechanisms have yet to be targeted. The
interdependence of the vascular system and bone remodeling process needs to be
explored further so that new treatment targets can be revealed and utilized. For
example, by stimulating angiogenesis and vascular remodeling, bone remodeling and
formation could be stimulated.

Impaired Vascular Function: PAOD
Peripheral arterial occlusive disease (PAOD), often referred to as peripheral
artery disease (PAD), is a major cause of disability and lifestyle changes worldwide
[44]. The cause of PAD is atherosclerosis in peripheral vessels and is defined by
ischemia in a patient’s extremities [44].
PAD has about 10% prevalence in the population with increasing occurrence
in elderly patients [44]. Some estimates number the individuals affected with PAD at
20 million in the United States [44]. In elderly patients there is a much higher
occurrence, and onset of acute limb ischemia attributed to PAD is typically related to
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increased risk of mortality and amputation in the effected limb [29]. Peripheral
atherosclerosis, which leads to PAD shares common risk factors with coronary artery
disease including: advanced age, female sex, diabetes, tobacco use, and hypertension
[17, 44]. Increased mortality has been observed when PAD is diagnosed in
conjunction with coronary artery disease [44, 45] and additional disease
comorbidities include chronic arterial disease, hip fracture, lower extremity
performance (measured by treadmill exercise duration) and decrease in bone marrow
density (BMD) [1, 17].
Diagnosis of the disease is primarily performed by using the Ankle Brachial
Index (ABI) which measures the blood pressure ratio between the ankle and arm,
during both rest and exercise [1, 44, 46]. Typically, symptoms arise when the ABI is
less than 0.8, with pain and tissue loss occurring at values of <0.5 and <0.3,
respectively [44].
Growth of atherosclerotic plaques can progress gradually, mainly caused by
an accumulation of oxidized LDL (low density lipoprotein) in the subendothelial
space [47]. Atherogenesis leading to the development of PAD is a function of
turbulent flow in conduit arteries and subsequent inflammation of the endothelium
[47]. Specifically, subendothelial ox-LDL activates macrophages, leading to
oxidative stress, inflammatory response, plaque formation, and eventual endothelial
dysfunction. The larger the plaque becomes, the greater the vessel occlusion [47].
Development of PAD leads to lower-limb pain with exercise, also known as
intermittent claudication, and possible critical limb ischemia [17, 45], lower limb pain
at rest. Disease progression is most often undetected due to the gradual nature of
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disease onset and ordinarily has asymptomatic presentation until reaching a critical
level [44].
Pathophysiology of the disease usually takes on the following characteristics.
Flow induced collateral dilation occurs in the side stream collaterals near the
occlusion as an acute response to a developing plaque [17]. Chronic response occurs
via vascular remodeling, and appears to result in the decrease of collateral resistance
over time, but distal resistance associated with the microvasculature does not change
significantly in symptomatic patients [17].
Often in symptomatic patients, the endogenous vascular compensation
response is impaired, including lacking the capacity for vasodilation, severely
diminishing the capacity for repair [45, 48]. Depending on the tissue characteristics,
remodeling activity will vary. An arcaded vascular network experiences primarily
arteriogenesis, where as a dendritic network experiences more angiogenesis and some
arteriogenesis. [12]. In a diseased state unable to compensate, blood flow becomes
restricted in affected tissues and ischemia will result, leading to inefficient nutrient
delivery, eventually resulting in a tissue death [8].

PAOD and Osteoporosis Link
A large majority of the research of PAD has been in muscle [8, 12, 15, 16, 24,
27, 29, 45, 48, 49], leaving implications in bone poorly defined. However, recent
findings may bridge the gap to bone by relating chronic ischemic disease and
osteoporosis. High level associations between PAD and hip fracture are explained by
age, lower bone mineral density (BMD) and poorer lower extremity performance
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(based on treadmill walking) [1, 35], including direct associations between
osteoporosis and PAD in women [2]. Risk factors for osteoporosis and atherosclerosis
overlap; including advanced age, smoking, diabetes, and physical inactivity [1].
Furthermore, PAD occurrence is 5 times greater in women with osteoporosis than
women with normal BMD [3], femoral neck BMD is a predictor of PAD [3], and low
BMD correlates with calcification of atherosclerotic plaques [50].
Osteoprotegerin (OPG), which inhibits RANK mediated osteoclast activation,
shows increased levels in patients with PAD and may help explain initial
relationships between the two diseases [34, 50]. Prior discussion revealed that the
RANKL complex is implicated in local inflammatory bone loss by activation of
osteoclasts [9, 34]; and that local angiogenesis triggered by activation of RANK
contributing to vessel remodeling [9, 35]. In the case of osteoporosis, where there is
an excess of osteoclast activity, OPG production is stimulated by tumor necrosis
factor as a response to suppress the osteoclast activity, and by endothelial cells as an
autocrine anti-apoptotic factor [50]. Since there is increased OPG, which disrupts the
RANK / RANKL interaction, the angiogenesis may not be stimulated, resulting in
diminished capacity for bone remodeling. This may explain the ischemic and disease
condition based on bone physiology.
Vascular necrosis and chronic inflammation correlate to osteoporosis and
increased resorption through recruitment of osteoclasts to the site of endothelial
activation [9, 35]. Invading vasculature in bone is responsible for regulation of the
ossification process and angiogenesis is required for bone regeneration [9]. In a
patient with PAD the vasculature lacks the ability to acutely dilate or outwardly
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remodel, diminishing the capacity for structural vessel adaptation [17]. This vascular
impairment may lead to a diminished capacity for bone repair, thus leading to
osteoporosis.
Symptoms associated with PAD, namely intermittent claudication, may also
contribute to the development of osteoporosis. A patient’s activity will be restricted
with pain related symptoms, such that normal mechanical stimulus is diminished,
leading to bone removal associated with remodeling. And if bone resorption is due to
advanced age or estrogen deficiency, the mechanical integrity of the bone may be
compromised, leading to osteoporosis.
Aside from previously described treatments that target osteoporosis alone,
Vitamin D administration has seen positive results for patients with both PAD and
osteoporosis [51]. Vitamin D increases BMD in osteoporotic patients with PAD and
alleviates symptoms associated with lack of vitamin D, including bone aches, pain,
and weakness [51]. It was hypothesized that due to pain associated with both
diseases, the patients were less active, resulting in less vitamin D adsorption from the
sun [51]. This treatment strategy would be effective if the cause of the combined
disease stemmed from inactivity, as previously suggested.
While each hypothesis is plausible, determining the mechanism linking
osteoporosis and PAD will stem from initial examination of the effects of ischemia on
bone remodeling. Determining how parameters, such as vessel density and bone
remodeling, change with ischemia is crucial to understanding the interaction between
the two diseases.
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Aims and Hypotheses
As the first step to understanding the disease links, the main focus of this
research is to examine the physiologic responses to ischemia and fatigue loading on
bone remodeling. Interplay between bone remodeling and vascular remodeling has
been examined in fracture repair and in induced remodeling [52, 53], but little is
known regarding the remodeling response to an ischemic environment. Based on the
void in understanding, and in order to providing a foundation of initial observations,
the objectives of this thesis are:

1. Establish a protocol for use of immunohistochemistry for identification of
blood vessels in bone. The goal of this aim was to create a reliable method to
quantify the vascular changes in bone in response to ischemia and fatigue
loading.
2. Determine the effects of ischemia on tibial mechanical properties and
microvasculature, and examine any time dependence associated with the
changes. The purpose of this aim was to quantify and correlate changes in
vasculature in response to induced ischemia.
3. Determine if increased vasculature will occur in response to mechanical
fatigue loading, consistent with prior research. The goal of this aim was to
demonstrate the vessel identification protocol’s effectiveness and to determine
time dependant changes in the bone vasculature during load-induced
remodeling.

23

CHAPTER 2: IMPACT OF ISCHEMIA ON VASCULARIZATION AND
MECHANICAL PROPERTIES IN BONE

Introduction
Osteoporosis is likely caused by a change in the complex interactions among
regulators of bone cell function [34]. Treatments thus far have focused primarily on
regulating osteoclasts and osteoblasts, with limited success, but other cellular
mechanisms have yet to be targeted. Possible interdependence of the vascular system
and bone remodeling process needs to be explored further so that new treatment
targets can be revealed and utilized. There appears to be a correlation between male
patients with PAD and lower BMD [1], and a direct association between the two
diseases in elderly women [2]. This parallel disease occurrence suggests that PAD
related ischemia could cause or enhance the onset of osteoporosis, so in order to test
this hypothesis, it is necessary to know the direct impact of ischemia on bone. One
causal explanation is that hypoxia resulting from induced ischemia will result in
alteration of gene (VEGF, HIF) expression and cell (osteoclasts, endothelial cells)
activation, directly impacting BMU activity through the microvasculature. This
change in BMU activity could affect the bone’s mechanical properties and would be
directly dependent on local vasculature and blood supply.
As a starting point there are some known relationships between the vascular
system and bone tissue, but interaction between the two systems is largely
uncharacterized. Known associations include a linear correlation between total vessel
area and bone formation [54], and angiogenesis occurring in areas of bone formation,
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preceding mineralization [52]. The relationship between blood flow and bone
remodeling has been only slightly defined in a mechanically loaded environment [52].
Compared to structural adaptation in muscle, little is known about the
resulting mechanical or vascular changes attributed to diminished blood flow in bone.
Previous studies have primarily examined subchrondral bone and the immature
femoral head to elucidate the pathologic alterations resulting from ischemia [55, 56].
four weeks after an ischemic event, the subchrondral bone exhibited significantly
increased mineralization [55], and hypoxia induced local chrondrocyte death in the
region of ischemia [56]. Furthermore, revascularization in the subchrondral region
occurs within 4 weeks of ischemic event, but revascularization of the bone requires
more time [56]. Although somewhat narrow in scope, these studies have provided
initial observation of an ischemic environment in bone and lead to the possibility that
vascular changes precede bone formation and in areas of ischemia. This possible
relationship is one of the primary aims of the research presented in this chapter.
As a possible explanation for this relationship between vascularization and
bone formation, it appears that hypoxia and the hypoxia inducible factor (HIF-1)
pathway are intimately involved in bone’s response to ischemia [56, 57]. The HIF-1
pathway is activated in ischemic tissue [56], and consistent with muscle, the HIF and
vascular endothelial growth factor (VEGF) pathways are upregulated in bone in
response to hypoxia [57]. Specifically, VEGF and HIF-1 are upregulated in
osteoblasts in the region of distress, fracture, or hypoxia [57] and early angiogenic
response in adjacent cartilage is implicated in the revascularization process of bone
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[56]. Thus, the HIF-1 pathway couples the angiogenic and osteogenic pathways
during bone modeling and development [56].
Since the HIF pathway is active in ischemic regions, and HIF regulates
angiogenesis, the next step is to determine the extent of angiogenesis. Angiogenesis is
required for bone regeneration and osteogenesis [33, 57], but additional contributors
to the angiogenic response have not been examined. PECAM may facilitate
interactions between angiogenesis and osteogenesis [58], as it has been implicated in
angiogenesis thru endothelial activation signaling, cellular adhesion and
extravasation, and is expressed in hematopoietic-derived osteoclasts [58]. For bone
remodeling PECAM mediates normal osteoclastogenesis by binding the Syk protein
(which stimulates osteoclast precursor proliferation), regulating its downstream
effect. The PECAM knock-out mouse lacks the ability to bind Syk, leading to
unregulated osteoclast precursor proliferation and subsequently, increased
osteoclastogenesis and bone resorption [58], resulting in a diminished trabecular bone
volume [58]. For vascularization in the ischemic bone environment, there is an
upregulation of VEGF and PECAM, indicative of angiogenesis [56]. Thus, PECAM
appears to influence both bone remodeling, through osteoclast regulation, and
vascularization in bone.
These observations and conclusions are not unexpected, as complement
processes occur in muscle, but these conclusions help to reveal commonalities,
including HIF and PECAM, between revascularization and re-ossification, indicating
a need for further research. However, these studies did not examine cortical bone
changes or vascular alterations in mature bone. Because PAD and osteoporosis onset
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occurs in developmentally mature individuals, examination of mature bone is much
more applicable to the disease states. Due to the gap in understanding, one goal of
this project is to elucidate vascular necrosis and angiogenic changes in cortical bone
stemming from the response to ischemia. We also examined any mechanical changes
resulting from ischemia induced revascularization. If there is a vascular remodeling
response to the ischemic environment, as would be expected, we should see increased
in vasculature, followed by enhanced mechanical properties.
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Methods
Summary
Chronic ischemia was induced in the mouse by resection of the femoral artery
vein pair. Forty three C57BL/6 male mice aged 2-3 months were separated in to two
groups. All animals except for day 0 underwent the ischemia surgery, with one group
of mice designated to observe mechanical properties, while the second group was
used for histological assessment. The day 0 animals did not undergo any procedure
and served as a control time point. Each of these initial treatment groups was further
sub divided into four time points, Table 1. Depending on the designation, the tibias
from each animal were excised and prepared for either mechanical testing or
histology. A 3-Point Bending apparatus was used to elucidate mechanical properties
and immunohistochemistry (IHC) was employed for determining blood vessel density
in the cortical bone of the tibia.

Table 1: Experimental design and animal designation.
Displayed as number of animals per experiment at a given time point and procedure.
Time Point (Days)

Histology

Mechanical Analysis

0

4

4

7

5

4

14

6

8

28

6

6

All surgical procedures and animal handling was approved by the Institutional
Animal Care and Use Committee (IACUC) prior to experiment initiation.
Additionally, all surgical procedures were preformed in an aseptic environment. Mice
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were maintained in micro-isolation cages with a twelve hour light/dark cycle and ad
libitum access to feed and water.

Surgical Model of Chronic Ischemia – Femoral Artery Resection
Surgeries were performed under a stereomicroscope and animals were
anesthetized with isoflurane (1.5-2% in O2 at 1ml/min) throughout surgical
preparation and procedure. The hair on the medial aspect of each hindlimb was
removed with trimming clippers and depilatory cream, and disinfected with
chlorohexidine diacetate. Next, the animal was placed supine on a heating pad with a
rectal-feedback probe maintaining a 35º C temperature, with the animal’s nose in the
anesthetic mask. An incision was made on the medial aspect of the left hindlimb and
extended from the abdominal wall to just above the ankle. Connective tissue was
blunt dissected from the underlying skeletal muscle and skin, and sterile saline was
used to irrigate the wound. The nerve adjacent to the isolated artery-vein pair was
separated, being careful not to damage it. The femoral artery-vein (a-v) pair was
ligated with 6-0 silk suture proximal to the profunda femoris, and the saphenous a-v
pair was ligated halfway between the knee and ankle. The fat pad and accompanying
epigastric a-v pair were removed. The profunda femoris was cauterized at the
bifurcation from femoral a-v pair, and the saphenous vessel pair was cauterized just
distal to the ligation. Minor vessel branches from the main a-v pair were cauterized
prior to resecting the a-v pair away from the host tissue starting at the distal ligation
and terminating just distal to the proximal ligation. A depiction of the operation and
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region of vessel removal is displayed in Figure 6. The incision was closed using 7.0
polypropylene suture.

Figure 6: Depiction of resection surgery.
Region of vessel removed from the medial aspect of the left hindlimb. Dashed line
corresponds to the portion of vessel excised to induce the ischemic condition.

A contralateral sham surgery involved an incision of equivalent length and
location on the medial aspect of the right hindlimb, and blunt dissection of connective
tissue, just as in the previous limb. This sham procedure served as an internal control
for any effects of general surgical trauma. A subcutaneous injection of the analgesic
buprenorphine (0.075mg/kg) was delivered following the procedure and the animal
was allowed to recover until ambulatory in a heated chamber. A detailed surgical
protocol is reproduced in Appendix A.
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Tibial Excision and Preparation
At the assigned time point, the animals were euthanized by cervical
dislocation and both tibae were excised. Two methods were employed depending on
the continued use of the tibia. For mechanical characterization, an incision was made
in the medial aspect of the hindlimb and was extended the full length of the hindlimb.
The skin was separated and cut away from the underlying muscle from the proximal
end of the femur to the heel, exposing the distal tendons. All of the tendons were cut
at the ankle; the patellar tendon was also cut. All surrounding musculature around the
tibia and fibula was peeled off the bone and removed. The ankle and knee joints were
severed and the fibula was removed before the now isolated tibia was wiped clean of
any remaining tissue with a Kimwipe (Kimberly-Clark, Neenah, WI). Appendix A
details the full protocol. The excised tibae were then frozen at -20ºC for
approximately 72 hours before thawing and mechanically testing.
For histological experiments the tibia was excised in a similar manner. The
skin was removed and the patellar and ankle inserting tendons were cut, however,
only the gastrocnemius muscle was removed from the tibia and the fibula was left
intact as well. These two modifications provided better support during sectioning and
allowed for preservation of the periosteum [52]. Appendix A details the full protocol.
Once isolated, the tibias were immersion fixed in Histochoice (Electron Microscopy
Sciences, Hatfield, PA) for 48 hours. Samples were then decalcified for a minimum
of 5 days in EDTA (Sigma-Aldrich, St. Louis, MO) prior to processing and
embedding. The day 14 and 28 samples were washed and stored in phosphate
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buffered solution (PBS) following decalcification in EDTA until the samples were
processed and embedded.

Mechanical Property Testing
A servo controlled, 3-point bending apparatus was utilized to quantify the
material and mechanical properties of the tibia. Due mainly to length constraints, a 3
point apparatus instead of a 4 point apparatus, which provides more uniform loading,
was used [59]. Prior to placement into the testing tray, the tibae were thawed and
moistened with PBS. The bones were positioned with the anterior surface of the tibia
face down so that when the specimen is viewed at eye level the bone is in a concave
orientation; this orientation prevented movement of the tibia during the test, which
was a problem with the convex orientation. The two lower supports of the tray were
10mm apart and the third ‘point’ was brought down equidistant from each of the
lower two points to apply a load. The bones were tested in an anterior-posterior
orientation with the former face down. A load cell (500N, Applied Measurements
LTD, UK) was attached to the descending arm and force-displacement data was
gathered at 685Hz. The maximum displacement allowed after contact with the bone
was 1mm, with the actuator moving at 2mm/min, as per the guidelines put forth by
the testing protocol. The 1mm maximum displacement sufficiently captures the
fracture event, without recording superfluous data after the fracture. The apparatus
and set up is displayed in Appendix B.
At the conclusion of the test the outside and inside diameters were measured
at the point of fracture. The measuring apparatus is depicted in Appendix B. Along
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with equations described by Jamsa [60], detailed in Table 1, the Ultimate load (N),
Ultimate stress (Pa), Elastic modulus (Pa) and stiffness (N/mm) were obtained.

Table 2: Equations used for Mechanical Property Characterization [60]

Variable of Interest
Stress

Equation Used

σ=

Elastic Modulus

FL(routside / 2)
4I

E=

Moment of Inertia
I=

FL3
d (48) I

π ( Doutside 4 − Dinside 4 )
64

Legend
σ = stress
F = Force
L = Support spacing
routside = Outer radius
I = Moment of inertia
d = Displacement
Doutside = Outer diameter
Dinside = Inner diameter

Immunohistochemistry
Identification of vessels was performed by staining an endothelial-specific
glycoprotein with GS-1 Lectin. Following the fixation and decalcification, the bones
were cut in half transversely at the midshaft, dehydrated, and impregnated with
paraffin wax in an automated processor before embedding in paraffin wax. Using a
RM 2255 (Leica Microsystems, Buffalo Grove, IL) microtome, 6 µm sections were
cut from the blocks starting at the midshaft. The sections were mounted on Super Up
Rite – Bond Rite slides (ThermoFisher Scientific, Houston, TX) and incubated at
80˚C for ten minutes. After a xylene wash and a graded ethanol rehydration series,
antigen retrieval was performed using citrate buffer (RICCA Chemical Co.,
Arlington, TX) at 95˚C for 10 minutes. Treated slides were washed in PBS for 20
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minutes before 1 hour incubation of Biotinylated GS Lectin I at 10µg/ml (Vector
Labs, Burlingame, CA). Vectastain AB enzyme (Vector Labs, Burlingame, CA),
prepared in accordance with the manufacturer’s directions, was applied for a 30
minute incubation. After a PBS wash, the slides were developed with peroxidase and
DAB substrate kit (SCBT, Santa Cruz, CA) for 15 minutes. Half of the samples were
counterstained with 0.5% Methyl Green (Fisher Scientific, Houston, TX). A final
distilled water rinse, and ethanol and zylene dehydration were executed before
coverslip application. Appendix A details the full protocol.
Finished samples were imaged using bright field microscopy (Olympus,
Center Valley, PA) and a Retiga Exi camera (Q Imaging, BC, Canada). Vessel
densities as a percentage of the total tibial area were determined with the use of
Image J (NIH, Bethesda, MD).

SpO2 Measurements
The induction of an ischemic environment in the hindlimb as a result of the
surgical intervention was validated using a pulse oximeter (Mouse STAT, Kent
Scientific, Torrington, CT). Additionally, time to reperfusion following the resection
procedure was of interest, and the SpO2 measurements quantify the degree of
reperfusion. For all measurements, the ‘cuff’ was placed around the arch of the
hindpaw. Hindlimb pulse oxygenation was recorded prior to the resection surgery,
immediately after the resection surgery, and just prior to euthanizing the animal at the
prescribed time point for tibial excision.
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Statistical Analysis
A two way ANOVA was used to identify statistical differences. If applicable,
comparisons were made between the operated and sham tibia, using a Student’s t –
test, and comparisons were made between time points and bone regions using one
way ANOVA. Some of the figures display percent change data, which was
normalized by the averaged day 0 data. Results are expressed as mean ± SE.
Statistical significance was set p < 0.05, unless otherwise stated.
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Results
Induction of Ischemia
Hindpaw oxygen tensions were not different between the two hindlimbs prior
to surgery, but levels were significantly diminished in the operated hindlimb
immediately following the procedure, Figure 7. Based on the significant decrease in
SpO2 in the distal hindlimb, it can be concluded that ischemia was indeed induced by
the surgery. Comparison of the operated hindlimbs before and after the procedure
revealed a post surgical decrease in SpO2 levels, furthering the notion of an induced
ischemic environment. Interestingly, the unoperated hindlimb showed an increase in
SpO2 levels following the surgery (P < 0.001).

Sham Hi ndl imb
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Resected Hindl i mb

90
80

%SpO2
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60
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a

40
30
20
10
0
Pre-Surgical

Post Surgical

Figure 7: %SpO2 in the hindlimb prior to and immediately following surgery.
Black bar is contralateral sham and Grey bar is operated hindlimb.
* p < .05 vs. sham. ‘a’ p < .001 vs. pre-surgical
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Reperfusion of the ischemic hindlimb appeared to have occurred prior to day
7, as no differences were observed between time point specific operated and nonoperated hindlmbs, and there were no differences between the three time points (p =
0.206), Figure 8.

Figure 8: %SpO2 in hindlimb at each time point following induced ischemia.
Black bar is contralateral sham and Grey bar is operated hindlimb.

Mechanical Properties
In accordance with the hypothesis, the thought is that mechanical property
changes will give insight into the degree of bone remodeling and modeling occurring.
Quantification of mechanical properties is presented as a way to test the hypothesis.
Tibial stiffness was not significantly different from the contralateral sham at
day 7 or day 14, but stiffness was increased at day 28, Figure 10. However, there was
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no change in stiffness between time points before or following the ischemic event.
Interestingly, day 0 and day 28 sham stiffness was significantly lower than day 7.

Figure 9: Force – Displacement curve from 3 point bend test.
Linear portion of trace, used for stiffness calculation, and
ultimate load point is clearly visible as the peak in the trace.
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Figure 10: Tibia stiffness by time point.
Day 0 is un-operated control. Black bar is contralateral sham and Grey bar is
operated hindlimb. * = p < .05 vs. sham at Day 28. ‘a’ = p < .05 vs. Day 7 sham.

The ultimate load data showed similar findings associated with the tibial
stiffness. There was not a significant increase in the resected compared to sham at any
time point, but there was trending towards statistical significance for the resected data
at day 28 (p = 0.061 with 57% Power), Figure 11. However, there were not any
significant differences between the ischemic time points. Additionally, unlike the
stiffness data, there were no differences between the sham time points.
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Figure 11: Ultimate Load by time point.
Day 0 is un-operated control. Black bar is contralateral sham and Grey bar is
operated hindlimb.

Ultimate stress and modulus were not different between time points or
between the ischemic and non-ischemic tibae (data in Appendix C).
The systemic changes in bone mass were quantified with cross-sectional
cortical thickness measurements at the site of fracture. Figure 12 depicts the field of
view used to obtain measurements. No differences were seen in the data, and there
were no differences between time points for either the resected or sham groups,
Figures 13.
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Figure 12: Microscope field of view for thickness measurement.
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Figure 13: Cortical Thickness at each time point.
Black bar is contralateral sham and Grey bar is operated hindlimb.

Quantification and correlation of bone mass characteristics with the
mechanical data were analyzed with cross-sectional area. There was a significant
increase at day 14 compared to sham, however, the sham data was significantly
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decreased at day 14 compared to day 7, Figure 14. No differences were observed
across the resected time points using a one-way ANOVA (P = 0.3).
1.2
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Figure 14 : Cross sectional bone tissue area, by duration after surgery.
Black bar is contralateral sham and Grey bar is operated hindlimb.
* p < .01 vs. sham. # p < .05 between Day 7 and 14 sham data points.

Histological Analysis
Analysis of tibial cross sections encompassed quantification of several
parameters including regional bone area and cortical vessel number. Vessel densities
were calculated as the number of positively marked vessels per square millimeter in
the photomicrographs. Figure 15 illustrates positively marked vessels in cortical bone
of the tibia.
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Figure 15: Positive and control vessel marking in cortical bone.
10x region overview (A, D) with dashed box indicating region of magnification. 40x
view (B, C, E, F) of specified region. Positively stained vessels are marked with
white, closed, arrows (B,E). The respective serial controls (no primary antibody) are
marked with black, open, arrows (C, F). The image on the left depicts vessels of a
Day 14 resected tibia and the right image illustrates vessels in a Day 28 resected tibia.
Grey scale bar is 150 µm and black scale bar is 50 µm.
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Vessel density increased at day 14 compared to sham, and both day 14 and 28
were significantly increased compared to day 7 and day 0, Figure 16. There were no
differences between time points for the sham data points.
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Figure 16: Vessel density by time point.
Day 0 is un-operated control. Black bar is contralateral sham and Grey bar is
operated hindlimb. * = p < .05 vs. sham at Day 28. Both ‘a’ points are
significantly different from both ‘b’ points and vice versa p < .01.
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Discussion
The majority of the conclusions will be discussed in detail in Chapter 4 with
this section serving as an overview of findings. The data in Figure 10 suggest that
there may be bone modeling in the sham tibia by day 7, evidenced by the significant
increase in stiffness. Furthermore, the data suggest bone removal and/or remodeling
is occurring in the sham hindlimb by day 28, as the stiffness returns to a pre-surgical
level.
For the ischemic hindlimb, it seems that remodeling is occurring in response
to ischemia, evidenced by the increase in stiffness at day 28 and the trending of the
ultimate load data. It appears that the ischemia alone is triggering the remodeling,
most likely through angiogenesis, substantiated by Figure 16. In response to the
induced ischemia there is a marked increase in vascular density in the bone by day 14
and that increase from the day 0 and day 7 baseline is sustained until day 28.
Interestingly, the most significant increase in vasculature occurs at day 14, prior to
any observed mechanical changes. Because of this, it appears that the vascular
response is driving the mechanical and remodeling response, such that an increase in
vasculature, resulting from the ischemia, is directly affecting bone remodeling.
Although similar interpretations have been made for bone modeling in fracture repair,
this is the first examination of direct ischemia effects.
The vasculature is required for bone remodeling, but the seemingly direct
connection of the ischemic environment to stimulated remodeling is a novel
observation. Furthermore, it appears that angiogenesis is sufficient for bone
remodeling and this ischemic influence on bone remodeling could further our
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understanding of the system interactions. Thus, the stimulation of angiogenesis alone
could have an effect on bone, providing new treatment strategies for patients with
both PAD and osteoporosis.
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CHAPTER 3: IMPACT OF INDUCED BONE REMODELING ON
VASCULARIZATION

Introduction
Osteoporosis is generally described as a systemic skeletal disease,
characterized by deterioration of bone micro-architecture leading to increased bone
fragility [34, 36]. Specifically, osteoporotic bone contains fewer and narrower
trabeculae, attributed to loss in osteocyte density and viability [37-39]. Fracture is the
primary risk for patients with osteoporosis and there are 1.5 million fractures per year
in the US [41]. Osteoporosis and related fractures in the Americas and Europe
contribute to the loss of 2.8 million disability adjusted life years (DALY) [40], which
accounts for 1.75% of DALYs for non communicable diseases in western society and
0.83% of worldly DALYs [42]. Based on the disease prevalence and lack of robust
treatment options, osteoporosis is an important area of research.
Osteoporosis is likely to be caused by a change in the complex interactions
among the regulators of bone cell function [34]. Normally, bone experiences
microdamage from physiologic loading and adapts through targeted sculpting of the
bone tissue [31]. This repair and shaping of bone is executed by the basic
multicellular units (BMUs), composed of osteoclasts that remove tissue and
osteoblasts that deposit tissue into the tissue void [31]. A remodeling event
commences when osteocytes (mature osteoblasts) experience elevated or diminished
loads and undergo apoptosis, a potent bone remodeling stimulus [31]. The integration
of these three cell types, along with intracellular signaling drives the remodeling of
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bone. In a patient with osteoporosis, the cellular interactions are altered, resulting in
an increase in bone removal that is unmatched with bone deposition. Tissue removal
is the first part of the remodeling process [61], and with inadequate bone deposition,
the bone loses structural integrity. From this information, we can conclude that
osteoporosis is intimately related to the bone remodeling process.
Greater understanding of the pathophysiology of osteoporosis requires greater
comprehension of basic bone remodeling and further knowledge regarding these
processes may provide insight into new treatment targets and for osteoporosis
treatment. In both fracture repair and mechanical loading experimental models, the
physiologic response is heavily influenced by bone modeling, remodeling, and
vascular growth processes, which is why remodeling regulation is studied in these
contexts. In fracture repair models, vasculature invades the void caused by the
fracture and accompanying osteoclasts degrade any local cartilage or matrix [9].
Vascular changes precede bone formation [33], thus, angiogenesis must occur and, in
fact, angiogenesis is necessary for the first stage of fracture healing [33, 62]. As the
vasculature advances into the region of repair, for reasons unknown, angiogenesis can
be aided by osteoblasts stimulated by a load ‘shock wave’ that results in indirect
production of VEGF and contributes to local angiogenesis [9]. Callus deposition,
which is a bony formation comprised mainly of woven bone, is prevalent in these
types of fracture repair models [53]. It appears that the woven bone does not undergo
classical bone remodeling, and merely acts as a 'splint' while cortical bone modeling
and remodeling transpires in the region of fracture [53]. Additionally, the woven bone
response provides the majority of the structural integrity during the post fracture
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repair [53]. Although not directly tied to osteoporosis, fracture repair research reveals
basic interactions between the vascular growth and remodeling pathways, which may
lead to further understanding of the physiologic deficiencies seen in osteoporotic
bone.
Because osteoporosis is dependent on remodeling, examination of only the
remodeling response is most closely relatable to the disease. The way to assess
normal, physiologic bone modeling and remodeling is through stimulation of bone
using mechanical loading. Mechanical loading is utilized to propagate bone
microdamage, which induces bone remodeling, even in mice, which don’t undergo
regular remodeling under normal conditions. This practice is well defined [32, 33, 52,
53, 63] and alters the interstitial shear stress experienced by osteocytes, driving
osteoblast and osteoclast activity based on the amplitude of stress and any resultant
osteocyte apoptosis [32], and thus, mechanical stimulation is sufficient for BMU
associated remodeling [32]. Additionally, the protein periostin, expressed in
osteoblast precursors, becomes upregulated with increases in applied mechanical
stress and regulates osteoblast differentiation and adhesion, which is necessary for
new bone formation [64].
A variety of outcomes have been observed as a result of mechanical loading,
including a significant increase in periosteal woven bone [53] and the role of
trabecular bone in microdamage propagation. The trabecular bone is a porous
structure comprised of both rod and plate-like elements [65], with an anatomical
depiction of these structures shown in Figure 17. Longitudinal rod density appears to
determine the propensity for induced microdamage, even though these structures
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account for only a small fraction of the total tissue [65]. Since microdamage is a very
robust stimulation for bone remodeling, induction of microdamage is a critical
outcome of mechanical loading. Typical axial loading results in one directional
deformation, but in transverse loading, trabeculae bending occurs [66]; which seems
to be a likely method for microcrack development [65, 66]. Coupled with the finding
that remodeling events transpire in the direction of loading [32] and remodeling is
proportional to fatigue damage [33], the magnitude of bone formation and remodeling
can be modulated based on the apparatus and associated loading parameters.

Figure 17: Trabecular bone representation.
Rod elements are shaded and plate elements are opaque [67].

Compared to fracture healing, little is known regarding the contribution of
vascularization and specific cellular remodeling interactions (between osteoclasts and
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endothelial cells, for example) in response to loading. Previous macro scale
observations regarding the interaction of bone modeling, remodeling, and
vascularization include: magnitude of fatigue damage is proportional to vascular
changes [33] and vascular increases (number and area) are correlated with fatigue
magnitude [52]. Vessel size and number also increase with loading and appear to
occur in areas of bone formation, with a maximum occurring 2mm distal from the
midshaft of the tibia [52]. From a chronological perspective, vascular alteration
occurs before bone deposition, with the vasculature providing a spatial template for
loading associated bone formation [52]. These findings have mostly focused on bone
modeling, but research solely regarding remodeling events is novel. Since much can
still be learned regarding remodeling, opportunities for research are numerous. By
characterizing the normal bone remodeling response, possible osteoporosis treatment
targets can be realized. Progressing from these ideas, this study hopes to visualize and
quantify vascular changes in the cortical and periosteal bone in response to axial
loading and subsequent bone remodeling. Spatial and loading duration considerations
will also be included to further understand interplay between the vascular system and
bone remodeling in hopes of better understanding the normal bone remodeling
process.
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Methods
Summary
Bone remodeling was induced in a mouse model by axially loading the tibia in
a cyclic manner. To determine the vascular response to physiologic loading animals
were subject to either 2 weeks or 5 weeks of loading. Tibae were excised following
the determined loading duration and were analyzed for vessel density in the cortical
and any newly formed bone using IHC.
All procedures were approved and conducted in accordance to IACUC
guidelines. Six month old mice were maintained in micro-isolation cages with a
twelve hour light/dark cycle ad libitum access to feed and water.

Mechanical Loading 1
Animals were anesthetized with isoflurane (1.5-2% in O2 at 1ml/min)
throughout the loading procedure. Once the animal was at an appropriate plane of
anesthetic, it was placed supine on a custom platform within an EnduraTEC Elf3220
(Bose, Framingham, MA), with its left heel stabilized in a fixed location. A small
fixture attached to the load cell was then lowered onto the proximal head of the
vertically oriented tibia, until a preload of .2N was established to prevent movement
during the procedure. The cyclic loading cycle was run with the following
parameters: sinusoidal waveform, 1200 cycles at 4 Hz and an applied load range of 1
to 3.2 N. The right hindlimb of the animal was left unloaded to serve as the
contralateral control. Each animal was loaded for 5 consecutive days followed by two
1: Mechanical Loading Procedure was performed by Josiah Kessler
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days of rest per week. The animals were loaded for either 2 weeks (n = 3) or 5 weeks
(n = 6).

Tibial Excision and Preparation
At the conclusion of the prescribed loading duration, the animals were
euthanized by cervical dislocation and both tibae excised. An incision was made in
the medial aspect of the hindlimb and was extended the full length of the hindlimb.
The skin was separated and cut away from the underlying muscle from the proximal
end of the femur to the heel, exposing the distal tendons. All of the tendons were cut
at the ankle; the patellar tendon was also cut. Only the gastrocnemius muscle was
removed from the tibial segment in order to provide better support upon sectioning
and for preservation of the periosteum [52]. The ankle and knee joints were severed,
and once isolated, the tibias were immersion fixed in Histachoice (Electron
Microscopy Sciences, Hatfield, PA) for 48 hours. Samples were then decalcified for a
minimum of 5 days in EDTA (Sigma-Aldrich, St. Louis, MO) prior to processing and
embedding.

Immunohistochemistry
Identification of vessels was performed by staining an endothelial-specific
glycoprotein with GS-1 Lectin. Following the fixation and decalcification detailed
previously, the bones were cut in half transversely at the midshaft, dehydrated, and
impregnated with paraffin wax in an automated processor before embedding in
paraffin wax. Using a RM 2255 (Leica Microsystems, Buffalo Grove, IL) microtome,
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6 µm sections were cut from the blocks starting at the midshaft. The sections were
mounted on Super Up Rite – Bond Rite slides (ThermoFisher Scientific, Houston,
TX) and incubated at 80˚C for ten minutes. After a xylene wash and a graded ethanol
rehydration series, antigen retrieval was performed using citrate buffer (RICCA
Chemical Co., Arlington, TX) at 95˚C for 10 minutes. Treated slides were washed in
PBS for 20 minutes before 1 hour incubation of Biotinylated GS Lectin I at 10µg/ml
(Vector Labs, Burlingame, CA). Vectastain AB enzyme (Vector Labs, Burlingame,
CA), prepared in accordance with the manufacturer’s directions, was applied for a 30
minute incubation. After a PBS wash, the slides were developed with peroxidase and
DAB substrate kit (SCBT, Santa Cruz, CA) for 15 minutes. Half of the samples were
counterstained with 0.5% Methyl Green (Fisher Scientific, Houston, TX). A final
distilled water rinse, and ethanol and zylene dehydration were executed before
coverslip application. Appendix A details the full protocol.
Finished samples were imaged using bright field microscopy (Olympus,
Center Valley, PA) and a Retiga Exi camera (Q Imaging, BC, Canada). Crosssectional area and circumferential measurements were made for each of the zones
illustrated in Figure 18 based on sample images. Vessel densities as a percentage of
the total tibial area were determined with the use of Image J (NIH, Bethesda, MD).
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Figure 18: Tibia cross sections illustrating the regions of analysis.
Two examples of tissue sections divided by anatomical position for
regional quantification of vessel densities
Statistical Analysis
A two way ANOVA was used to identify statistical differences. If applicable,
comparisons were made between the loaded and non loaded leg, using a Student’s t –
test, and comparisons were made between loading duration time points and bone
regions using one way ANOVA analysis. Results are expressed as mean ± SE.
Statistical significance was set p < 0.05, unless otherwise stated.
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Results
Quantification of parameters including: regional bone area, regional and cross
sectional circumference, periosteal vessel number, and intracortical vessel number
will provide insight to the degree of vascular remodeling in relation to bone structure
changes. Vessel densities were calculated as the number of positively marked vessels
per square millimeter in the photomicrographs. Figure 19 illustrates positively
marked vessels in both the intracortical and periosteal regions of the tibia.
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Figure 19: Positive and control vessel marking, intracortical bone and
periosteum.
10x region overview (A, D) with dashed box indicating region of magnification (both
cortical and periosteal tissue is captured in all images). 40x view (B, C, E, F) of
specified region. Positively stained cortical vessels are marked with white, closed,
arrows and positively stained periosteal vessels are marked with black, open, arrows
(B, E). The respective serial controls (no primary antibody) are marked in a similar
fashion (C, F). The image on the left depicts vessels of a 2 week loaded tibia and the
right image illustrates vessels in a 5 week loaded tibia.
Black scale bar is 150 µm and white scale bar is 50 µm.
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Vessel density was significantly increased in the two-week loaded tibae
compared to the contralateral control and 5-week loaded tibae, Figure 20.

Figure 20: Total vessel density for both 2 and 5 week loading cycles.
Black bar is control tibia, Grey bar is loaded tibia.
* p < .05 vs. control, # p < .05 vs. experimental time points.

Analyzing only vessels within the intracortical bone, vessel density is
significantly increased compared to control at 2 weeks, but not at 5 weeks.
Additionally, the 5 week control vessel density is significantly greater than the 2
week control density, Figure 21. Furthermore, the 2-week intracortical vessel density
ratio is significantly increased compared to the 5-week vessel density ratio, Figure
22. The ratio was calculated as the loaded tibia vessel density over the control tibia
vessel density.
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Figure 21: Intracortical vessel density for both 2 and 5 week loading cycle
Black bar is control tibia, Grey bar is loaded tibia.
* p < .01 vs. control. # p < .05 vs. 2 week control
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Figure 22: Intracortical vessel density ratio for 2 and 5 week loading cycles.
Ratio is Loaded density / Control density.
* p < .01 vs. control.
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Though differences were observed for total cortical bone vessel density, no
such conclusions were supported for periosteal density, calculated as the number of
vessels within the periosteal region per circumferential length, Figure 22,

Figure 23: Periosteal vessel density for both 2 and 5 week loading cycles.
Black bar is control tibia, Grey bar is loaded tibia.

Regional analysis of the tibial cross sections revealed only one difference;
after 2 weeks of loading there was a significant increase in the total lateral vessel
density, Figure 23. It seems that the large difference seen in the lateral region is
greatly affecting the results regarding total tissue characteristics.
For a majority of the time points the standard error is quite large, due to the
fact that some samples within a time point and specific area did not exhibit positive
staining. Interestingly, the control, 2 week, medial data point did not have any
positive staining in the data set, reflected in the figure.
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Figure 24: Regional vessel density for both 2 and 5 week loading cycles.
Black bar is control tibia, Grey bar is loaded tibia.
* p < .05 vs. control.
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Discussion
The majority of the conclusions will be discussed in detail in Chapter 4 with
this section serving as an overview of findings. The histological data points to a time
and location dependence for changes in vascular density in mechanically loaded
tibiae. It appears that at 2 weeks of mechanical loading, there are regional,
intracortical and total increases in vessel density. Additionally, observed differences
compared to control at 2 weeks are no longer seen at the 5 week loading time point.
These two observations can be explained simultaneously with a few key findings. As
discussed previously, bone overuse leads to increased bone remodeling [61]. It has
been demonstrated that the initial loading stimulus, rather than the long-term
stimulus, has a greater impact on bone formation and remodeling [61]. A reasonable
explanation for the dependence of bone formation on initial loading stimulus, and
why changes are observed at two weeks and not at five week, are 'desensitization' of
bone cells occurring with increased loading durations, evidenced by a bone formation
plateau [61]. Through cytoskeletal reorganization within the osteocyte due to routine
loading, the mechanosensitivity and activation threshold is altered, resulting in
diminished bone formation and remodeling over time [61]. If there is a correlation
between vascularization and bone formation/ remodeling, Figure 20 would support
the desensitization hypothesis.
Figures 21 and 23 reveal regional and intracortical differences in vascular
densities. Lateral changes are explained by high levels of local strain and previous
research has shown increased matrix mineralization in the lateral region in response
to mechanical loading [68]. And consistent with prior conclusions, these changes are
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only observed at the 2 week loading time point. Interpretation of the intracortical
vessel density changes may prove to be much more meaningful. Bone modeling
occurs in the periosteal region with mechanical loading [53], so one can hypothesize
that remodeling is the primary process occurring in the intracortical bone, as there are
few modeling events in mature bones in the intracortical region. With this
assumption, and the fact that vasculature is required for bone remodeling, the increase
in intracortical vessel density at 2 weeks appears to be indicative of remodeling
events. If that is indeed the case, it seems that the apparent remodeling profile is time
and somewhat location dependent. Extrapolating to osteoporosis, if the vasculature is
intimately involved with the normal remodeling response, this interaction and time
dependence could be targeted as a possible treatment target or diagnostic.
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CHAPTER 4: DISCUSSION

The governing objective of this study was to determine the role of the vascular
system in the context of bone remodeling induced by mechanical loading and
ischemia. Understanding the vascular role in the bone remodeling and modeling
processes may reveal treatment strategies for patients with osteoporosis and
concurrent PAD. The aims of the thesis listed below will guide the discussion.
1

Establish an immunohistochemistry protocol to identify blood vessels in bone.

2

Determine the effects of ischemia on tibial mechanical properties and
microvasculature, and examine any time course of the changes.

3

Determine if vascularization will occur in response to mechanical fatigue
loading, consistent with prior research.

Aim 1: Immunohistochemistry Protocol Development
Overview
Most conventional vascular quantification methods used in muscle (ink fill,
polymer casting, side stream imaging, whole mount imaging, and laser Doppler) are
not feasible in bone due to tissue location and/or structure, namely, the anatomically
deep and calcified nature of the tissue. Because of this, little work has been done
regarding blood vessel quantification in bone in the context of remodeling.
Immunohistochemistry (IHC) was used to circumvent some of the bone specific
imaging restrictions present with whole mount and in vivo procedures. The IHC
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protocol aimed to provide replicable and consistent vessel quantification utilizing
basic histological techniques.
Of the few prior studies that used IHC in bone, all but one examined staining
bone marrow, and in one instance, a VEGF-A antibody was used as a spatial
quantification stain in trabecular bone. Other studies have also done some ink
fill/polymer casting, but the published procedures were not well replicated in the local
lab setting. Based on the apparent lack of publications using IHC, its use for cortical
bone staining is uncommon, and this appears to be the first time that Lectin has been
used in this specific application.
Biotinylated GS Lectin I was utilized in the protocol after a PECAM antibody
failed to yield any positive staining. The Lectin used is highly targeted, attaching to
an endothelial-specific glycoprotein.
Some challenges arose due to the lack of prior information regarding Lectin
IHC in cortical bone. Tissue section integrity reduced sample efficiency due to the
heat antigen retrieval and bone-tissue slide adhesion. Additionally, some bone tissue
degradation may have occurred in the day 14 and 28 samples that underwent an extra
PBS rinse prior to tissue processing. This possibility may help explain the results
observed in Figure 14, where the bone crosssectional area was diminished at day 14
compared to other time points. Peroxidase incubation times were highly sensitive and
were subsequently optimized to provide sufficient positive staining without
sacrificing image clarity and positive contrast. Because the protocol using Lectin was
new, the resolution of the stain was not very high, most likely staining fewer vessels
than were actually present in the tissue, compared to other published vascular data
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[52]. Furthermore, counterstaining of the sections using Methyl Green, Hematoxilyn,
and Eaosin did not provide improved contrast and identification of positively marked
vessels.
Despite these impingements, the protocol adequately met its goals and
provided quality stains for imaging and analysis. The success of the protocol is best
illustrated by Figures 15 and 19, which highlight the contrast between positively
stained vessels and their serial controls (no Lectin applied).

Future Work and Improvements
Although the protocol was repeatable and fairly efficient, additional
troubleshooting and optimization could be performed to increase the efficiency. Aside
from increasing the percentage of positively stained vs. unstained vessels, the
protocol could be improved with work pertaining to section integrity, heated antigen
retrieval, and peroxidase incubation times in order to increase image clarity and stain
contrast. An example of potentially unstained vessels is shown below, Figure 25.
One improvement would be optimization of peroxidase incubation times, reduction of
the temperature for the antigen retrieval, and more tightly controlled heating
apparatus. Also, the addition of a future counterstain may help improve image quality
and vessel identification.
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Figure 25: Example Unstained Vessels.
40x view (A, B, C) of 2 Week loaded bone. Positively stained vessels are marked
with black arrows and possible unstained vessels are marked with white arrows
(A, C). The serial control (no primary antibody) vessels are marked
with dashed arrows, B. White scale bar is 50 µm.

Aside from the specific Lectin application, the bone-tissue preparation and
basic procedure enables the protocol and tissues to be utilized for different IHC
staining and apoptosis staining, with some optimization. The basic IHC protocol can
accept a different primary antibody other than the Lectin, for labeling other structures.

67

Aim 2: Ischemic Effects on Vascularization and Mechanical Properties.
Overview
Due to the correlation between osteoporosis and PAD, the vascular system
may play a critical role in the development of these diseases. One way to understand
and isolate the involvement of the vasculature in bone processes is through induction
of ischemia. Any resultant remodeling response in bone would most likely be driven
primarily by the vascular response, as minimal mechanical changes are directly
induced. Understanding the vascular contribution (and if it is necessary) to bone
processes and properties is vital to better understand the bone remodeling process and
osteoporosis implications.

Inducing Ischemia and Physiologic Response
From the pulse oximetery data presented in Figure 7, we can conclude that
ischemia was induced as a result of the surgical procedure. Angiogenesis does occur
in muscle as a result of the ischemia and hypoxia [15, 29], with vessel density in
muscle increased at day 7 through day 35 [69]. Additionally, proliferative activity of
endothelial cells is a maximum at day 7, still increased at day 14, but subsequently
falls back to control levels by day 21 [69]. In line with these findings, we would have
expected to see a decreased pulse oximetery in the operated leg up until day 14 but
the data presented in Figure 8 did not reflect this, most likely due to low instrument
consistency and accuracy. Ultimately, if the vascular and bone remodeling processes
are linked, hypoxia and resulting angiogenesis would be the initial processes involved
in explaining the relationship. Angiogenesis is necessary for bone modeling, so we
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are testing the hypothesis that independent angiogenesis will be sufficient for bone
modeling and/or remodeling. We are relying on hypoxia to drive an angiogenic
response that is independent of mechanical stimulation.

Vascularization in Bone
The vascular system is, at the minimum, implicated in the bone modeling and
remodeling processes, as evidenced by previous work associated with aim 3. In
response to the induced ischemia there is a marked increase in vascular density in the
bone by day 14 and that increase from the day 0 and day 7 baseline is sustained until
day 28, Figure 16. This result points to increased angiogenesis stemming primarily
from the ischemic condition. In order to support the robust angiogenic response, there
has to be extensive endothelial proliferation. Some pruning of vessels, or rarefaction,
may also occur after the initial angiogenic response, evidenced by lack of difference
between the day 28 operated and unoperated limbs, while the operated limb is still
greater than day 0 and 7.
Since the vasculature is changing, the next step is to determine how this
change may affect the bone processes. Most often, tissue necrosis occurs to some
degree in an ischemic environment, necessitating removal and repair of damaged
tissue. And since the osteoclasts are the cells responsible for tissue removal in bone,
the vasculature may interact with the osteoclasts in the following way. As previously
discussed, osteoclast recruitment is tied to the RANK / RANKL complex interaction;
RANK is an osteoclast membrane receptor and RANKL is the associated ligand
expressed on endothelial cells and osteoblasts [9]. While poorly understood, it is
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thought that endothelial cell adhesion, through the RANK complex, relocates the
osteoclasts from preexisting vasculature into the tissue of interest where they execute
their function [9]. Thus, increased endothelial cell proliferation could lead to
increased osteoclast activation and extravasation. Applied to this study, if
proliferation is occurring between day 7 and 14, osteoclast-enabled tissue removal
could be occurring during a similar time frame, with removal being the first step in
the remodeling process after initial hypoxia induced angiogenesis.
Confounding these findings is the notion of bone disuse. Due to the surgical
procedure, the animals tended to favor the un-operated leg, possibly leading to a
disuse case, leading to bone removal and diminished bone growth [61]. If this is
occurring, then the necrosis and remodeling bone removal would no longer be the
sole contributing factor. No study has specifically addressed the vascular implications
of unloading, but trabecular bone formation and PECAM expression decreased with
unloading by day 7 and was back to baseline levels after 7 days of normal activity
[70]. In this case, the vascular implications weren’t directly assessed, as only PCR
data was used, but as previously described, the PECAM protein could play a role in
the vascular response including angiogenesis. This finding may support my
hypothesis as disuse appears to have an inhibitory effect of vascular pathways.
Conversely, but not directly translatable, increased osteogenesis and angiogenesis
occur in response to HIF upregulation in defect repair [71], which points to the
ischemia related response influencing the processes independently.
The vascular factor, VEGF, involved in the ischemic response may also have
substantial effects on osteoclasts, as the osteoclasts express VEGF receptors tied to
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the RANK complex [35]. VEGF expression is upregulated in bone with exercise, and
VEGF inhibition prevented bone gain and vascular adaptation in exercising rats [35].
Additionally, it is thought that VEGF mediates bone angiogenesis (mirroring its role
in muscle) and is coupled with increased osteoblast activity during early response to
exercise [35]. Furthermore, only cells adjacent to capillaries give rise to bone tissue
and eventual mineralization (because of the RANK / RANKL interactions between
the osteoblasts, osteoclasts, and endothelial cells), therefore implicating any
surrounding vasculature in the bone processes [9, 34]. From these findings we can
deduce that the invading vasculature is a primary factor implicated in the bone
remodeling processes.
A higher level discussion of the effect on the processes themselves will come
in the following section, but as it pertains to this research and sequence of vascular
and bone processing events, the most significant increase in vasculature occurs at day
14, prior to any observed mechanical changes. Because of this and for the reasons just
outlined, it appears that the vascular response is driving the bone remodeling
response, such that an increase in vasculature, resulting from the ischemia, is directly
affecting bone cell function. Although similar interpretations have been made for
bone modeling in fracture repair, this is the first examination of direct ischemia
effects.
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Mechanical Property Implications
The data presented in Figure 10 lends itself to a variety of conclusions that tie
nicely into the observed vascular response. Starting with the sham hindlimb, the data
suggests that there may be bone modeling in the sham tibia by day 7, evidenced by
the significant increase in stiffness. Furthermore, the data suggest bone removal
and/or remodeling is occurring in the sham hindlimb by day 28, as the stiffness
returns to a pre-surgical level. This change can be attributed to increased loading of
the sham tibia for a week post-operatively, as the animal tends to favor the nonoperated limb, primarily based on every other day observation until the animal was
not longer ‘limping’. Since bone modeling results from increased loading, the bone
properties will change, and when the increased stimulus is removed when the animal
regains normal function, the bone will likely undergo some tissue removal and
remodeling.
For the ischemic hindlimb, it seems that remodeling is occurring in response
to ischemia, evidenced by the increase in stiffness at day 28 and the trending of the
ultimate load data. Coupled with the vascular data presented and the possible
molecular interactions discussed prior, it appears that the ischemia alone is triggering
the remodeling response, most likely through angiogenesis related processes
(endothelial cell proliferation, VEGF expression, or both). The emergence of a
difference in mechanical properties at day 28 fits with the idea of vascular changes
driving remodeling changes.
Remodeling results in an increased mineralization of the bone tissue changing the
mechanical properties [55]. Most notably, an increase in mineralization, and resulting
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increase in stiffness, enhances the brittle nature of the bone leading to an increased
susceptibility to microcracks or whole bone fractures [55]. Because there is an
increase in stiffness at day 28, we can conclude that remodeling may be transpiring.
We hypothesize that the following is resulting from the ischemia and influencing
bone remodeling:
1. Ischemia is induced with resulting hypoxia and tissue necrosis
2. Osteoclast recruitment closely follows the resulting angiogenic response
through RANK/ VEGF interactions
3. Tissue removal occurs between day 7 and day 14 (commencing the
remodeling process) as vasculature advances
4. Remodeling process proceeds and systemic changes are observed by day 28

From this hypothesis it appears that the bone remodeling process can be
stimulated solely by a vascular response to ischemia. Previous work seems to support
facets of this finding and help explain how these interpretations were made. In
patients with PAD, where tissue necrosis is increased, there is a reduction in nutrient
supply which impairs the bone repair process, which points to the necessity of a
vascular response [3]. There is also a decrease in bone formation attributed to
ischemia at day 10 and 14, again indirectly implicating the vascular system with bone
processes [72]. In regards to time scale, in humans it takes 20 days for initiation and
tissue removal by osteoclasts prior to any bone formation occurring in a specified 2
dimensional plane [61], and although not specifically defined, due to the similarity
between BMUs in mice and humans, we may be able to assume the removal
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timescale in mice is similar. This removal time scale fits well with the hypothesis, as
remodeling processes may be occurring by day 28. The hypothesis outlining the
possible interaction between the vascular and bone processes is highly relatable to
osteoporosis treatment, and will be discussed later, especially in understanding
disease onset in patients with osteoporosis and PAD.
With osteoporosis, the patient has lower BMD and stiffer bones (tied to the
brittleness of the tissue). If tissue necrosis occurs, the vasculature and osteoclasts will
respond. This will lead to even more bone resorption and greater risk to the patient. In
a patient with PAD, however, the result may be more critical. With PAD, a greater
amount of necrosis may occur and the vascular response will most likely be
diminished due to the disease pathogenesis. This may be problematic as the response
to tissue hypoxia will still result in VEGF expression, effectively recruiting more
osteoclasts. And without the vasculature in place to allow for the full remodeling and
bone deposition process, the bone tissue will necrose and be resorbed, amplifying the
osteoporotic condition. This hypothesis may explain the connection between PAD
and osteoporosis.
It is known than the vasculature is required for bone remodeling, but the
seemingly direct connection of the ischemic environment to stimulated remodeling is
a novel observation. Furthermore, it appears that angiogenesis is sufficient for bone
remodeling and this ischemic influence on bone remodeling could further our
understanding of the system interactions. Thus, the stimulation of angiogenesis alone
could have an effect on bone, in the long term. There would likely be a period of
damaged (microcrack or necrosis) tissue removal, but over time, the angiogenic
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response would provide the framework for bone growth and repair. In this capacity,
stimulating angiogenesis could provide new treatment strategies for patients with both
PAD and osteoporosis.

Future Work
Continuation of this research should involve quantification of any occurring
remodeling, so that the proposed hypothesis would be better supported. Additional
experiments involving isolated, non-exercising post-operational recovery could also
be performed to further isolate the ischemic response. To determine the role of disuse,
an array of treatments could be applied. One treatment could look at disuse and
ischemia vs. disuse control and other would be observing disuse in the short term for
both hindlimbs, followed by normal use. Disuse could be accomplished by nerve
crushing or tail suspension. These varying treatments would reveal contributions of
the disuse mechanism, as well and furthering the ischemic coupled bone remodeling
hypothesis.
Validation of the time course and possible causal relationship of the
vasculature to remodeling could also be performed. Angiogenesis could be stimulated
at particular intervals and for varying durations in order to reveal the time course for
any resultant bone remodeling. One angiogenesis stimulant could be a HIF gene
therapy. Upregulation of HIF, and use of bone marrow-derived mesenchymal stem
cells (BSMCs), and increased osteogenesis and angiogenesis in defect repair have
been detailed in previous studies [71]. By directly inducing an angiogenic response,
the bone remodeling response could be defined as a function of both time and
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stimulation amplitude. Some of these experimental treatments could translate into the
clinical realm.
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Aim 3: Vascularization in Response to Induced Remodeling
Overview
Bone remodeling and the BMU are highly implicated in the development of
osteoporosis [34, 39]. Additionally, the microvasculature is critical in the bone
remodeling process [9], but the degree to which vasculature is involved in
osteoporotic onset is not well defined. Establishing the vascular contribution to the
remodeling process may reveal treatment opportunities for remodeling-dependent
pathologies such as osteoporosis.

Previous Research Comparison
Although not specifically quantified, prior studies indicated that a majority of
the increases in vascularization occurred in the periosteal region [52], however this
study shows no such findings. Additionally, at day 14, and at a similar strain value,
previously quantified increases in vessel number were around 200% [52], compared
to 70% increase in vessel density seen in this study. Several factors, including
methodology and analysis, may explain this discrepancy. As previously mentioned,
the IHC most likely stained less vessels than were actually present in the tissue,
compared to other published vascular data [52], and despite a significant result
presented in this paper, it was not as robust as previous findings. Due to the IHC
resolution issues, data was presented as vessel density, opposed to total vessel number
or percent change from day 0, which may shield additional similarities between the
two studies.
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Vascularization in Response to Induced Remodeling
Based on the objective, the results support the observation of an increase in
vasculature from induced mechanical loading. This occurrence was only seen in the
day 14 loaded animals and not in the day 35 animals. A similar result has been shown
previously, vessel size and number increases with mechanical loading at day 14 [52],
and can be explained by osteocyte responses. Fluid shear and tissue strain increases
due to the load, triggering the Wnt signaling pathway leading to osteogenesis [68]. As
previously established, vasculature is required for bone formation, thus an increase in
vasculature is seen by day 14 in order for bone formation to occur. However, the
initial stimulus, rather than the long-term stimulus, has a greater impact on bone
formation [61], which can explain the vessel density disparity at the day 35 time point
compared to day 14. A reasonable explanation for the dependence of bone formation
on initial loading stimulus, and why changes are observed at two weeks and not at
five weeks, are 'desensitization' of bone cells occurring with increased loading
durations, evidenced by a bone formation plateau [61]. Through cytoskeletal
reorganization within the osteocyte due to routine loading, the mechanosensitivity
and activation threshold is altered, resulting in diminished bone formation and
remodeling over time [61]. If there is a correlation between vascularization and bone
formation/ remodeling, Figure 20 would support the desensitization hypothesis. It is
also possible that by day 35, some pre-study existing bone is no longer utilized (due
to the change in applied load), leading to its removal, along with any associated
vasculature [61]. This hypothesis is supported by the decrease of vessel density in the
day 35 time point compared to day 14. However, without directly quantifying the
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amount of remodeling that is occurring over time, it is hard to speculate on what the
changes in vascular density are supporting; whether it’s modeling and maintenance or
the remodeling process.
Examining vascular density changes from a more specific view, regional
analysis revealed an increased vessel density in the lateral region and may be
described by increased load and decreased sclerostin in the region of formation.
Sclerostin is a molecule normally secreted by osteocytes in a homeostatic
environment and acts to suppress the osteogenic response. However, strain suppresses
production of sclerostin, leading to increased bone formation through the
diminishment of osteogenic regulation [68]. In the tibial loading model, some of the
highest compressive stain is seen in lateral region [68, 73], stimulating bone growth
in that area, with previous research showing increased matrix mineralization in the
lateral region in response to mechanical loading [68]. And consistent with prior
conclusions, these changes are only observed at the 2 week loading time point. In
both of these scenarios, vascularization is necessary in order for the osteogenic
process to occur, thus increased levels of vessel density are seen in the lateral region
of the loaded tibias.
Understanding of induced bone modeling and remodeling has accompanied
observations regarding bone vasculature. Bone modeling appears to occur in the subperiosteal region with mechanical loading [53], so one can hypothesize that if
remodeling is occurring, it would arise in the cortical bone. Because the main
mechanical stimulus for remodeling is changing strain and microdamage, this can
only occur in fully mature bone, which in this experimental case, only exists in the
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cortical region. With this assumption, and the fact that vasculature is required for
bone remodeling, the increase in cortical vessel density at 2 weeks appears to be
indicative of remodeling events. If that is indeed the case, it seems that the apparent
remodeling profile is time and location dependent. Extrapolating to osteoporosis, if
the vasculature is intimately involved with the normal remodeling response, this
interaction and time dependence could be targeted as a possible treatment target or
diagnostic; for example, using contrast CT to quantify vascularization in the bone
tissue to draw conclusions about the bone tissue health (necrosis, density).
As the most basic conclusion from this study, we can interpret the data as
vascularization being concurrently implicated in the bone response to mechanical
loading. And since we know that modeling (in response to the applied loads and
resultant strain changes) and remodeling (in response to induced microdamage and
subsequent repair) occurs in response to loading, we can conclude that the
vascularization is concurrently implicated in the remodeling and modeling of bone.
Moving forward from this study, we know that vascularization is necessary for bone
remodeling [9], and based on the presented data, vascularization seems to be
stimulated by mechanical loading in areas of preexisting bone. Since vascular growth
precedes remodeling and bone formation, these findings can be applied as a treatment
for osteoporotic patients; as it appears that loading can provide stimulation for
increased vascularization in preexisting bone, hopefully resulting in bone growth
and/or remodeling. One way to accomplish mechanical stimulation is using vibration,
which has shown increased bone mass [74]. Although the effect of loading has been
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proven helpful [74], our data suggest that the positive remodeling effect can be
increased and modulated by loading duration and frequency.

Future work
It needs to been seen whether the observed increase in vasculature is
correlated to increased bone remodeling. Quantification of the integrity of osteocytes,
with an apoptosis stain, both regionally and between cortical and periosteal tissue,
will lead to more robust interpretations and understanding of the interaction between
the vasculature and bone remodeling. Similarly, a model of short-term loading cycle
and lengthened recovery along with remodeling analysis might elucidate the sequence
between bone formation and loading stimulus. If a sequence is fully defined, we can
then interpret the findings as a causal relationship between the vascular and bone
systems. Furthermore, quantification of skeletally mature (6 month) C57 day 0
animals could lead to more definitive conclusions regarding time dependence.
C57 mice are more sensitive than most animals to mechanical loads, including
more bone gain per unit of strain [75], so future experiments involving other animal
models may more closely simulate the human physiologic response. Additionally,
experiments examining only vascular gain of function treatments would be beneficial
to observe if a mechanical stimulus is required for bone remodeling, or if only a
purely vascular stimulus will result in bone formation and remodeling. For this type
of study, all involved cells (osteoclasts, osteoblasts and osteocytes) as well as
osteocyte apoptosis would need to be quantified in order to determine the amount of
remodeling. Associated findings would be directly relatable to the treatment of
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osteoporosis as modulation of the bone remodeling process is the key component of
the disease.

Final Thoughts
We have shown the concurrence and causal relationship of the vasculature to
the bone remodeling process and have furthered our understanding of the seemingly
intimate interaction of the two physiologic systems. These findings could be
especially helpful in new treatment strategies that mainly target the vascular system
or that incorporate the interaction of the two systems. There are some emerging
treatments that can benefit from increased understanding.
Vitamin D administration has seen positive results for patients with both PAD
and osteoporosis, as vitamin D increases BMD in osteoporotic patients with PAD and
alleviates symptoms associated with lack of vitamin D, including bone aches, pain,
and weakness [51]. Prolyl hydroxylase (PHD) inhibitors increase angiogenesis and
could increase capacity for bone regeneration if used in osteoporotic patients [57].
Exercise and low level vibration can increase bone formation, decrease bone
resorption, raise peak bone mass, and enhance bone strength, and may be able to be
used concurrently with a vascular treatment to improve efficacy [74]. Also, with
bisphosphonates (BP) treatment, osteoprotegerin (OPG) is positively correlated with
BMD [76], which is to be expected because OPG regulates the osteoclasts and may
have an effect on osteoblasts.
By taking into account the vascular and bone systems, the application of this
study could be instrumental in further research and clinical application.
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APPENDIX A: PROTOCOLS

Hindlimb Ischemia Surgery - Resection
Mouse Information
DOB: ____________________________
Sex: ____________________________
Tag:
Genotype/strain: ___________________
Cage: ____________________________

____36.

Materials
Autoclave in Surgical Instrument Container
____1.
Standard pattern forceps (1)
____2.
S&T forceps (2)
____3.
5-45 forceps (1)
____4.
Iris scissors (1)
____5.
Microdissection scissors (1)
____6.
Castroviejo (1)
____7.
Retractor (1)

Surgery
____39.

____37.
____38.

____40.
____41.
____42.

____43.
Autoclave in Surgical Pack
____8.
4 x 4 gauze sponge (3)
____9.
cotton swabs (12)
____10.
6.0 silk suture (2 x 1-inch)
____11.
Surgical drape (1)

____44.
____45.

Obtained in surgery suite
____12.
sterile Petri dish w/ sterile saline
____13.
sterile gloves
____14.
sterile 7.0 prolene suture
____15.
heat-cautery
____16.
FST heat pad w/ rectal probe
____17.
Recovery heat pad
____18.
recovery bin & weigh boat
____19.
depilatory cream
____20.
non-sterile cotton swabs
____21.
non-sterile 2 x2 gauze sponge
____22.
isolation mask & cap
____23.
analgesic (Buprenorphine)

____46.

____47.
____48.
____49.
____50.
____51.
____52.

Surgery preparation
____24.
Spray surgery area with Nolvasan
____25.
Weigh animal in weight boat
____26.
Place animal in anesthesia box
____27.
Open the oxygen cylinder and set
anesthesia-machine flow meter to ~3
l·min-1
____28.
Anesthetize animal w/ 5% isoflurane
____29.
Reduce flow rate to 0.5-1.0 l·min-1 and
the isoflurane to 1-3%
____30.
Apply ear tag high on left ear
____31.
Lay animal supine with nose in nosecone
____32.
Shave hair on the right and left hindlimb
& lower abdomen with clippers
____33.
Remove excess hair with depilatory
cream
____34.
Spray right and left hindlimb with
Nolvasan
____35.
Return animal to anesthesia box

Lay animal supine on circulating heat pad w/
nose in nose-cone
Insert rectal probe and set thermo-controller
to 35°C
Apply veterinary ointment to eyes to avoid
drying during procedure

Make a small incision on the middle, medial
aspect of the left thigh
Extend the incision up to the abdominal wall
Blunt dissect the subcutaneous connective
tissue to maximize surgical exposure
Use cautery to remove fat pad overlying
femoral a-v pair & cauterize epigastric a-v
pair
Blunt dissect the femoral artery-vein pair
from the nerve starting just upstream to the
muscular branch & extending to half-way
between the knee & ankle
Tie off the saphenous a-v pair with 6.0 silk
suture, halfway between the knee & ankle
Tie off the femoral a-v pair with 6.0 silk
suture, halfway just upstream to the muscular
branch
Grasping the distal ligature, use the cautery &
microscissors to remove the a-v pair up to the
upstream ligature
Gently rest cotton swabs on hemorrhage sites
Use 6.0 polypropylene suture to close the
skin
Make a small incision on the middle, medial
aspect of the right thigh
Extend the incision up to the abdominal wall
Blunt dissect the subcutaneous connective
tissue to maximize surgical exposure
Use 6.0 polypropylene suture to close the
skin

Post-Surgical
____53.
Give the animal an subcutaneous injection of
buprenorphine (0.075mg/kg)
____54.
Place the animal in the recovery bin, on a
blue bench cover, above a heat pad and allow
to recover
____55.
Turn flow meter down to 0, turn off
isoflurane, and close the oxygen cylinder
____56.
Indicate surgery on cage card
Notes
_________________________________________________________
_________________________________________________________
_________________________________________________________
_________________________________________________________
_________________________________________________________
_________________________________________________________
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Figure 26: Surgical station with instruments.
Key components are labeled and indicated with arrows.
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Tibial Dissection – Mechanical Testing
Mouse Information
DOB: _____________________
Sex:_______________________
Tag: ______________________
Genotype/strain: _____________
Cage: _____________________
Materials
____57.
____58.
____59.
____60.
____61.

Standard pattern forceps
S&T forceps
Iris scissors
Microdissection scissors
Bone scissors

____62.
____63.
____64.

Kimwipes (2)
Centrifuge vials (2)
Tape

Dissection preparation
____65.
Place animal in anesthesia box
____66.
Open the oxygen cylinder and set anesthesia-machine flow meter to ~3 ml·min-1
____67.
Anesthetize animal w/ 3% isoflurane
____68.
Perform cervical dislocation on animal to euthanize
____69.
Lay animal supine and tape forepaws down
Dissection
____70.
Make a small incision on the middle, medial aspect of the left thigh
____71.
Extend the incision up to the proximal head of the femur and down to the ankle
____72.
Blunt dissect the subcutaneous connective tissue and remove the skin around the
hindlimb
____73.
Using the microdissection scissors, cut the tendons and ligaments at the ankle joint
including the Achilles
____74.
Sever the patellar tendon with the microdissection scissors
____75.
Peel off all surrounding musculature from tibia and fibula
____76.
Using the bone scissors, cut at the knee and ankle joints to separate the tibia/fibula
____77.
Remove the fibula using the bone scissors
____78.
Wipe off any remaining tissue from the tibia using the Kimwipe
____79.
Place the excised tibia in a properly labeled vial
____80.
Repeat process for right hindlimb
Post-Dissection
____81.
Record animal usage in the log
____82.
Place the animal in the in a sealed plastic bag and then into the biohazard bag
____83.
Put the vials (containing the tibae) into the freezer
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Tibial Dissection – Histology
Mouse Information
DOB: _____________________
Sex:_______________________
Tag: ______________________
Genotype/strain: _____________
Cage: _____________________
Materials
____84.
____85.
____86.
____87.
____88.

Standard pattern forceps
S&T forceps
Iris scissors
Microdissection scissors
Bone scissors

____89.
____90.
____91.

Kimwipes (2)
Centrifuge vials (2)
Tape

Dissection preparation
____92.
Place animal in anesthesia box
____93.
Open the oxygen cylinder and set anesthesia-machine flow meter to ~3 ml·min-1
____94.
Anesthetize animal w/ 3% isoflurane
____95.
Perform cervical dislocation on animal to euthanize
____96.
Lay animal supine and tape forepaws down
Dissection
____97.
Make a small incision on the middle, medial aspect of the left thigh
____98.
Extend the incision up to the proximal head of the femur and down to the ankle
____99.
Blunt dissect the subcutaneous connective tissue and remove the skin around the
hindlimb
____100. Using the microdissection scissors, cut the Achilles tendon
____101. Sever the patellar tendon with the microdissection scissors
____102. Peel off the gastrocnemius muscle
____103. Using the bone scissors, cut at the knee and ankle joints to separate the tibia/fibula
____104. Place the excised tibia in a properly labeled vial
____105. Repeat process for right hindlimb
Post-Dissection
____106. Record animal usage in the log
____107. Place the animal in the in a sealed plastic bag and then into the biohazard bag
____108. Fill vials (containing the tibae) with Histachoice
____109. Store vials at room temperature and in an appropriate location
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Immunohistochemistry
Endothelial Cell Marker Lectin Checklist: Paraffin Embedded Sections
Incubation
Time
10 min
10 min
3 min
3 min
3 min
3 min
3 min
3 min
5 min
Antigen
Retreival
10 min

Reagent

60 min RT°

1° Lectin

30 min, RT

2° Streptavadin Use Vector AB Kit :2.5ml PBS, 1 Drop A and
Mix, 1 Drop B and Mix
D-PBS pH 7.4
DAB Substrate – when light brown color is observed put in

3 min
15 min

Oven at 80 C (setting 7) after sections mounted on slides
Xylene
100% EtOH
100% EtOH
95% EtOH
85% EtOH
70% EtOH
50% EtOH
Distilled Water
Rice cooker at 95 C for 10 min (samples in Citrate Buffer)
D-PBS pH 7.4
GS1 in D-PBS
Use .1 ml Lectin and 4.9 ml PBS (10 ug/ml)

ddH2O

3 min
10 seconds
10 seconds
30 seconds

Distilled Water
95% EtOH
100% EtOH
Xylene
Xylene + permount

Study
Staining performed by
Date
/
/

.

Associated protocol description and notes
After sectioning, place the slides in the tray and place the tray in the oven in
the orientation shown in Figure 31 to ensure tissue attachment on the edges of the
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slides. Additionally, 10 minutes is an estimate, leave in the oven until the slides are
translucent, at which time place immediately into the xylene.

Figure 27: Slide tray placement in the oven.
Tray is indicated by white arrow.

The xylene and ethanol hydration steps should be performed in the hood and
in the solution dishes. Place and remove the slide tray from dish to dish slowly and
gently to avoid tissue detachment. Illustration of a dish with the slide tray and the
array of dishes are shown below in Figure 32.
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Figure 28: Dish array and dish with slide tray.

During hydration steps, fill the rice cooker pot 1/3 with water, turn on the rice
cooker to the ‘Cook” position, and place a dish with citrate buffer in the cooker.
Cover the pot and periodically check the temperature with the thermometer until 95º
C is reached. For the antigen retrieval step, place the slide tray and thermometer in
the hot citrate buffer dish and replace the lid. The proper arrangement is illustrated in
Figure 33. Monitor the temperature and remove the lid for several seconds at a time
if the temperature is too high.
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Figure 29: Antigen retrieval set up.
Dish and thermometer is visible, with the ‘Cook’ light illuminated.

After the 10 minutes remove the slide dish and unplug the rice cooker. With
the hydrophobic pen, outline the tissues from each section to isolate them. Figure 34
below illustrates this technique.

Figure 30: Hydrophobic tissue outline
Blue circles represent the tissue, and the dashed lines represent the
hydrophobic pen outline.

95

After tissue outlining, place the slides into the paper towel lined incubation
Tupperware. Pipette the reagents, using the 1 ml pipette, onto the tissue, within the
hydrophobic outline. An example of incubating slides is shown in Figures 35 below.

Figure 31: Slides with reagent applied.
Top image, Lectin incubation. Bottom image, DAB incubation, with pipette visible.
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To remove the reagents, use the vacuum shown in Figure 36. Following all
reagent incubations, remove the any residual fluid before putting the slides back into
the tray. After all slides have been subject to 30 of xylene, take the slides out one at a
time and immediately apply mounting medium and coverslip. To prevent tissue
detachment, apply the mounting medium directly on top of the tissue. Let slides dry
overnight. The final step is shown in Figure 37 below

Figure 32: Reagent removal with vacuum.
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Figure 33: Completed slides.
Key components are labeled and indicated with arrows.
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APPENDIX B: APPARATUS AND EQUIPMENT FIGURES

Figure 34: Overview of the 3 Point Bending apparatus.
Key components are labeled and indicated by arrows.

Figure 35: Zoom view of bending apparatus.
Bone tray, load cell and point of contact are visible.
Arrow indicates location of tibia.
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Figure 36: Overview of the cortical thickness measurement apparatus
Key components are labeled and indicated with arrow.

Figure 37:Pulse oximeter device.
Hindpaw measurement cuff indicated with arrow
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APPENDIX C: ADDITIONAL DATA

Day

Ultimate Stress (MPa)

Elastic Modulus (Gpa)

Sham

Resection

Sham

Resection

28

282.4 ± 30.6

371.8 ± 77.5

4.4 ± .5

6.1 ± 1.5

14

276.0 ± 22.6

251.8 ± 28.9

4.2 ± .4

3.7 ± .5

7

265.1 ± 5.7

247.2 ± 51.4

3.9 ± .1

3.7 ± .9

0

218.6 ± 12.0

265.1 ± 24.6

3.2 ± .2

4.0 ± .5
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